See also this year's filing and all EDGAR filings for this company.
PDF Report 0001430306_2023_Tonix_Pharmaceuticals_Holding_Corp.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001430306, Tonix Pharmaceuticals Holding Corp.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 130,777,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 93,814,000 |
| 3 | remainder_Assets | 1,099,000 |
| 4 | LiabilitiesCurrent | 18,180,000 |
| 5 | LiabilitiesNoncurrent | 328,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 30,215,000 |
| 9 | ResearchAndDevelopmentExpense | 81,876,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,873,000 |
| 13 | remainder_ComprehensiveNetIncome | -75,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 225,690,000 |
| 1 | Liabilities | 18,508,000 |
| 2 | Expenses | 112,091,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 207,182,000 |
| 5 | NetIncome | -110,218,000 |
| 6 | ComprehensiveNetIncome | -110,255,500 |
| 7 | BaseVar | 179,118,500 |
| 8 | EconomicCapitalRatio | 2.02 |
Edgar->Model Mapping
Feature Distribution
Change over Time
